As of April 16, 2025, Morphic Therapeutic (MORF) has a market cap of $2.86 billion USD. According to our data, Morphic Therapeutic is ranked No.3428 in global market value.
Year | Market Cap | %Change |
---|---|---|
Aug 15, 2024 | $2.86 B |
97.32%
|
Dec 29, 2023 | $1.45 B |
7.96%
|
Dec 30, 2022 | $1.34 B |
-43.54%
|
Dec 31, 2021 | $2.38 B |
41.22%
|
Dec 31, 2020 | $1.69 B |
95.51%
|
Dec 31, 2019 | $0.86 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
![]() Ironwood Pharmaceuticals
IRWD
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
Market Cap | = | MORF Stock Price | * | MORF Shares Outstanding |
= | $56.99 | * | 50.22 M | |
= | $2.86 B |